These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 27099435)
21. Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. Zhang MH; Yuan YF; Liu LJ; Wei YX; Yin WY; Zheng LZ; Tang YY; Lv Z; Zhu F World J Gastroenterol; 2023 Aug; 29(31):4706-4735. PubMed ID: 37664153 [TBL] [Abstract][Full Text] [Related]
22. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
23. Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma. Huang JT; Liu SM; Ma H; Yang Y; Zhang X; Sun H; Zhang X; Xu J; Wang J J Cell Physiol; 2016 Feb; 231(2):328-35. PubMed ID: 26291451 [TBL] [Abstract][Full Text] [Related]
24. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients. Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226 [TBL] [Abstract][Full Text] [Related]
25. Complex interactions between microRNAs and hepatitis B/C viruses. Fan HX; Tang H World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078 [TBL] [Abstract][Full Text] [Related]
26. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients. Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740 [TBL] [Abstract][Full Text] [Related]
27. MicroRNAs involved with hepatocellular carcinoma (Review). Mao B; Wang G Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882 [TBL] [Abstract][Full Text] [Related]
28. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus. Hung CH; Hu TH; Lu SN; Kuo FY; Chen CH; Wang JH; Huang CM; Lee CM; Lin CY; Yen YH; Chiu YC Int J Cancer; 2016 Feb; 138(3):714-20. PubMed ID: 26264553 [TBL] [Abstract][Full Text] [Related]
29. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus. Tan Y; Ge G; Pan T; Wen D; Chen L; Yu X; Zhou X; Gan J PLoS One; 2014; 9(9):e107986. PubMed ID: 25238238 [TBL] [Abstract][Full Text] [Related]
30. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Hou J; Lin L; Zhou W; Wang Z; Ding G; Dong Q; Qin L; Wu X; Zheng Y; Yang Y; Tian W; Zhang Q; Wang C; Zhang Q; Zhuang SM; Zheng L; Liang A; Tao W; Cao X Cancer Cell; 2011 Feb; 19(2):232-43. PubMed ID: 21316602 [TBL] [Abstract][Full Text] [Related]
31. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model. Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation. Dundar HZ; Aksoy F; Aksoy SA; Tasar P; Ugras N; Tunca B; Egeli U; Cecener G; Yerci O; Kaya E Transplant Proc; 2019 May; 51(4):1157-1161. PubMed ID: 31101191 [TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037 [TBL] [Abstract][Full Text] [Related]
34. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer. Motawi TM; Sadik NA; Shaker OG; Ghaleb MH Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693 [TBL] [Abstract][Full Text] [Related]
35. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison. Shen S; Lin Y; Yuan X; Shen L; Chen J; Chen L; Qin L; Shen B Sci Rep; 2016 Dec; 6():38311. PubMed ID: 27917899 [TBL] [Abstract][Full Text] [Related]
36. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953 [TBL] [Abstract][Full Text] [Related]
37. Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus. Tan Y; Lin B; Ye Y; Wen D; Chen L; Zhou X Oncol Rep; 2015 Jun; 33(6):2863-70. PubMed ID: 25962820 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC). Shehab-Eldeen S; Nada A; Abou-Elela D; El-Naidany S; Arafat E; Omar T Asian Pac J Cancer Prev; 2019 Aug; 20(8):2515-2522. PubMed ID: 31450927 [TBL] [Abstract][Full Text] [Related]
39. Utility of a microRNA panel in diagnosis and prognosis of hepatitis C-associated hepatocellular carcinoma. ALrefai AA; Rizk SK; Khamis AK; Kasemy ZA; Habieb MSE Lab Med; 2024 May; 55(3):310-319. PubMed ID: 37695165 [TBL] [Abstract][Full Text] [Related]
40. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area. Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]